- Home
- RBC vs NBIX Comparison
RBC vs NBIX Comparison
Compare RBC & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBC
- NBIX
- Stock Information
- Founded
- RBC 1919
- NBIX 1992
- Country
- RBC United States
- NBIX United States
- Employees
- RBC N/A
- NBIX N/A
- Industry
- RBC Metal Fabrications
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RBC Industrials
- NBIX Health Care
- Exchange
- RBC Nasdaq
- NBIX Nasdaq
- Market Cap
- RBC 9.7B
- NBIX 11.0B
- IPO Year
- RBC 2005
- NBIX 1996
- Fundamental
- Price
- RBC $348.93
- NBIX $115.71
- Analyst Decision
- RBC Buy
- NBIX Strong Buy
- Analyst Count
- RBC 8
- NBIX 20
- Target Price
- RBC $357.67
- NBIX $163.20
- AVG Volume (30 Days)
- RBC 142.4K
- NBIX 1.8M
- Earning Date
- RBC 05-16-2025
- NBIX 05-05-2025
- Dividend Yield
- RBC N/A
- NBIX N/A
- EPS Growth
- RBC 22.03
- NBIX N/A
- EPS
- RBC 7.30
- NBIX 2.96
- Revenue
- RBC $1,612,300,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- RBC $6.13
- NBIX $15.36
- Revenue Next Year
- RBC $8.03
- NBIX $16.34
- P/E Ratio
- RBC $48.03
- NBIX $39.66
- Revenue Growth
- RBC 4.63
- NBIX 21.73
- 52 Week Low
- RBC $260.53
- NBIX $84.23
- 52 Week High
- RBC $372.83
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- RBC 61.92
- NBIX 60.88
- Support Level
- RBC $337.43
- NBIX $105.45
- Resistance Level
- RBC $346.02
- NBIX $130.46
- Average True Range (ATR)
- RBC 7.72
- NBIX 4.31
- MACD
- RBC 2.86
- NBIX 1.96
- Stochastic Oscillator
- RBC 87.42
- NBIX 50.22
About RBC RBC Bearings Incorporated
RBC Bearings Inc is an international manufacturer and marketer of highly engineered precision bearings, components and essential systems for the industrial, defense and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The end market is the United States of America. The company has two reportable segments: Aerospace Defense segment represents the end markets for the company's highly engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and Industrial segment represents the end markets for the company's engineered bearings and precision components used in various industrial applications. It derives maximum revenue from Industrial Segment.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.